Announced
Synopsis
Brocacef Group, a pharmaceutical sevices & ICT services, agreed to acquire 20 Dutch pharmacies from Ceban Pharmaceuticals, a pharmaceutical company. Financial terms were not disclosed. “With the acquisition of the compounding activities of Brocacef Ziekenhuisfarmacie, Ceban Compounding strengthens its position on the Dutch market for drug compounding, both extramural and intramural. The acquisition contributes to the growth of Ceban Pharmaceuticals and its ambition to become a leader in Europe in the field of compounding,” Jeroen van der Hamsvoort, Ceban Pharmaceuticals CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.